Management of symptomatic patients with suspected mild-moderate COVID-19 in general practice. What was published within the first year of the pandemic? A scoping review

Figures & data

Figure 1. Inclusion flow chart.

Table 1. Settings and patient populations of the included studies.

	Number of studies	Median number of patients (range when applicable)
Community	20	297.5 (13–4182)
Adult patients	9	400 (87–4182)
Adult patients with prior infection	8	548 (24–2112)
Adults and children	1	180
Healthcare workers	1	293
Healthcare workers with prior infection	1	13
General practice	6	353.5 (61–743)
Adult patients	3	73 (61–518)
Adult patients with prior infection	1	743
Adults and children	1	360
Adults and children with prior infection	1	347
Hospital (outpatient or staff)	42	220 (50–12,022)
Adult patients	28	205 (50–2733)
Children	1	94
Healthcare workers	9	803 (132–12,022)
Healthcare workers with prior infection	1	160
Pregnant patients	3	158 (132–232)
Other primary care settings	4	129.5 (57–237)
Adult patients	3	167 (57–237)
Pregnant patients	1	92
Quarantine station or testing site	7	277 (60–3890)
Adult patients	7	277
Total	79	237 (13–12,022)

Table 2. Topics and designs.

	Randomised controlled trial	Diagnostic accuracy	Observational–prospective	Observational–retrospective	Mixed-methods and qualitative	Total
Therapy	11	0	2	3	0	16
Harm	0	0	1	0	0	1
Diagnosis	0	4	14	8	0	26
Prognosis	0	0	10	11	0	21
Other	0	0	6	7	2	15
Total	11	4	33	29	2	79

The term ‘prospective’ was used for all studies where patients were enrolled and subjected to predefined procedures or data collection instruments. The term also includes cross-sectional studies with no prospective follow-up. The term ‘retrospective’ was used for all studies where data was based on historical clinical data collected from for example charts.